Gene · 3313
NIH grants1,948
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 1,948
Download this page as JSON| Grant | Title | HSPA9 papers | Newest fiscal year |
|---|---|---|---|
| R01AR074875 | Mitochondrial inner membrane architecture in skeletal muscle pathophysiology | 1 | 2023 |
| R01CA160417 | Mitophagy in Tumor Microenvironment | 1 | 2023 |
| R01CA166413 | Mechanisms and Function of Autophagy in Cancer | 1 | 2023 |
| R01CA203737 | Targeting HER2-low breast cancer with 17p loss | 1 | 2023 |
| R01CA211070 | The Pancreatic Cancer Microenvironment | 1 | 2023 |
| R01CA232017 | NanoOptogenetic immunotherapy for B cell lymphoma | 1 | 2023 |
| R01CA233176 | Mitochondrial and nuclear functions of NKX3.1 in regulating oxidative stress in prostate cancer | 1 | 2023 |
| R01CA236118 | Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer | 1 | 2023 |
| R01CA236949 | Role of SETD5 in Chromatin Regulation and Tumorigenesis | 1 | 2023 |
| R01CA237027 | Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC | 1 | 2023 |
| R01CA237241 | Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes | 1 | 2023 |
| R01CA237563 | Phosphorylation-dependent regulation of GLI transcription factors | 1 | 2023 |
| R01CA238005 | Analysis of epithelial heterogeneity in prostate development and cancer | 1 | 2023 |
| R01CA240984 | An antisense RNA-mediated regulatory program that drives cancer metastasis | 1 | 2023 |
| R01CA243543 | Cellular Immunotherapy of Ovarian Cancer | 1 | 2023 |
| R01DA032444 | Effects of opiates on neurons and their impact on HIV neuropathology | 1 | 2023 |
| R01DK117655 | Small molecules targeting hepatic glucose production and insulin resistance | 1 | 2023 |
| R01DK118239 | Determining the Role of apoC-III in the Immune System | 1 | 2023 |
| R01DK120309 | Coactivator P300 promotes hepatic steatosis in obesity | 1 | 2023 |
| R01ES027593 | Altered Hippocampal Neurogenesis and Cognition via Maneb-mediated Changes in the Thiol Redox Proteome. | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3313/grants?page=25